A case report: identifying a novel variant in ELOC(TCEB1)-mutant renal cell carcinoma [0.03%]
案列报告：在ELOC（TCEB1）突变型肾细胞癌中识别新型变异体
Hai-Peng Cheng,Na-Mei Li,Ke-Xin Zeng et al.
Hai-Peng Cheng et al.
ELOC(TCEB1)-mutant renal cell carcinoma [ELOC(TCEB1)-RCC] is a newly recognized type of RCC characterized by clear cell morphology and ELOC(TCEB1) gene mutation. We analyzed one case with a point mutation in TCEB1 c.218T>A (p.V73E), which i...
A systematic review and meta-analysis of postoperative intervention effects in elderly patients with gastrointestinal cancer based on the protection motivation theory [0.03%]
基于保护动机理论的胃肠道肿瘤老年患者术后干预效果的系统评价和 Meta 分析
Yanhong Wei,Li Zhang,Zhenqi Wei et al.
Yanhong Wei et al.
Objective: This study aims to evaluate the effect of postoperative interventions based on the Protection Motivation Theory (PMT) on postoperative recovery in elderly gastrointestinal cancer patients, providing scientific ...
Tumor-cell HLA-DR expression as a potential biomarker of immunotherapy response in hepatocellular carcinoma [0.03%]
肝癌免疫治疗反应潜在生物标志物的肿瘤细胞HLA-DR表达量研究
Xinping Wang,Ningning Mao
Xinping Wang
Concetta Calabrò,Eleonora Cannella,Patrizia Nardulli
Concetta Calabrò
[This corrects the article DOI: 10.3389/fonc.2025.1563844.]. Keywords: C(nn) category; breast cancer; cost -...
Published Erratum
Frontiers in oncology. 2025 Nov 11:15:1734231. DOI:10.3389/fonc.2025.1734231 2025
Ying Zhao,Xiaoyu Song,WenFeng Luo et al.
Ying Zhao et al.
Post-translational modifications (PTMs) represent a pivotal regulatory mechanism in cellular processes, wherein the addition or removal of specific functional groups to amino acid residues dynamically modulates protein activity, subcellular...
A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer [0.03%]
代谢-放射免疫特征可预测非小细胞肺癌的治疗反应及免疫重塑
Zihong Zhu,Yichen Zan,Mengqian Jiang et al.
Zihong Zhu et al.
Objective: This study systematically investigates radiotherapy-induced metabolic remodeling across the TME, encompassing tumor cells, immune cells, and tumor-draining lymph nodes (TDLNs), and establishes a prognostic sign...
Association of preoperative controlling nutritional status score with clinical outcomes among surgical patients with esophageal cancer: a meta-analysis [0.03%]
术前营养状况评分与食管癌手术患者临床结局相关性meta分析
Yanli Ji,Lei Wang,Xiaoli Mei et al.
Yanli Ji et al.
Purpose: The aim of this study was to identify the relationship between preoperative controlling nutritional status (CONUT) score and long-term and short-term outcomes in patients with esophageal cancer receiving esophage...
Koya Yamashita,Zhilei Zhao,Keita Saito et al.
Koya Yamashita et al.
Hyperpolarized magnetic resonance imaging (MRI) has emerged as a transformative tool in cancer diagnostics, enabling real-time, non-invasive assessment of tumor metabolism. By employing hyperpolarized molecular probes, such as [1-13C]pyruva...
Comparative analysis of pancreatic cancer burden attributable to high BMI in adults aged 70 and older: analysis of the GBD data in the United States, Australia, and Germany (2012-2021) [0.03%]
基于GBD数据的美国、澳大利亚和德国成人中老年人群超重所致胰腺癌疾病负担的比较分析（2012-2021年）
Hanwen Yang,Simeng Lei,Yangkai Fu et al.
Hanwen Yang et al.
Background: Pancreatic cancer (PC) is a highly lethal malignancy for which obesity is a major risk factor. With increasing global aging, the burden of PC is increasing in the elderly population. ...
Case Report: Ablation as novel x therapy in the regimen for frail hematological malignancies with extramedullary lesion [0.03%]
病例报告：在虚弱的血液系统恶性肿瘤（伴有髓外病变）方案中使用消融作为新型x疗法
Muyun Wu,Shanshan Shi,Yan Guo et al.
Muyun Wu et al.
Hematological diseases, as a category of malignant tumors originating from the hematopoietic system, have long relied on treatments such as chemotherapy, radiotherapy, and hematopoietic stem cell transplantation. However, challenges remain ...